Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amwill Health CareBOM:544353 +0.56%42 EPS without NRI is ₹5.71 as of Mar. 2026. GuruFocus rates BOM:544353 with a GF Score™ of 42/100. The stock has 3 warning signs investors should review. Among 102 Medical Distribution companies, Amwill Health Care ranks better than 87.25% on this metric.
Amwill Health Care's earnings per share without non-recurring items for the
six
months ended in Mar. 2026 was ₹3.77.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.71.
During the past 12 months, Amwill Health Care's average earnings per share (NRI) Growth Rate was -14.20% per year.
During the past 3 years, the average earnings per share (NRI) Growth Rate was 42.20% per year.
During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for Amwill Health Care's EPS without NRI or its related term are showing as below:
BOM:544353'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 42.2 Med: 50.9 Max: 59.6
Current: 42.2
During the past 6 years, Amwill Health Care's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 59.60% per year. The lowest was 42.20% per year. And the median was 50.90% per year.
BOM:544353's 3-Year EPS without NRI Growth Rate is ranked better than 87.25% of 102
companies
in the Medical Distribution industry
Industry Median: 2.45
vs BOM:544353: 42.20
Amwill Health Care's EPS (Basic) for the
six
months ended in Mar. 2026 was ₹3.77.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹5.71.
Amwill Health Care (BOM:544353) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Amwill Health Care EPS without NRI Related Terms
Amwill Health Care EPS without NRI Historical Data
* Premium members only.
The historical data trend for Amwill Health Care's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544353 vs MCK, COR, CAH: EPS without NRI Comparison
For the Medical Distribution subindustry, Amwill Health Care's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amwill Health Care PE Ratio without NRI vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amwill Health Care's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where Amwill Health Care's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹5.71
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amwill Health Care (BOM:544353) has a EPS without NRI of ₹5.71 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Amwill Health Care and its competitors. According to the industry distribution chart, Amwill Health Care ranks #13 out of 102 companies in the Medical Distribution industry, placing it in the top 12.7%.
Is Amwill Health Care's EPS without NRI too high?
Amwill Health Care's current EPS without NRI is ₹5.71. Based on the distribution chart, Amwill Health Care ranks #13 out of 102 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amwill Health Care has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Amwill Health Care's EPS without NRI compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amwill Health Care ranks #13 out of 102 companies for EPS without NRI. This places Amwill Health Care in the top 13% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 2.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Distribution company?
The median EPS without NRI among Medical Distribution companies is 2.45, based on 102 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Amwill Health Care and its competitors. For the Medical Distribution industry, the median EPS without NRI is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amwill Health Care's current EPS without NRI is ₹5.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amwill Health Care stock overvalued right now?
Amwill Health Care (BOM:544353) has a current EPS without NRI of ₹5.71. The current EPS without NRI is ₹5.71. Amwill Health Care's overall GF Score™ is 42/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Amwill Health Care (BOM:544353), the current EPS without NRI is ₹5.71 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amwill Health Care Ltd is a derma-cosmetic development company. Its focus is on development of problem solving dermatological, cosmeceutical and aesthetical products. The product portfolio is divided into two categories, namely, development and contract manufacturing of generic dermatological solutions; and developing and formulating solutions to specific The company operates in only one segment which is dealing in pharma products.
42GF Score
Get the complete analysis for BOM:544353
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544353 has been successfully added to your 
